Hollis RL, Churchman M, Grimes GR, Meynert AM, et al. Somatic BRCA1/2 mutations are associated with a similar survival advantage to their germline counterparts in tubo-ovarian high grade serous carcinoma. Eur J Cancer 2025;219:115299.
PMID: 39955805